Request Appointment Patient Portal Telemedicine Consent Physician Referrals Research Referrals
  • facebook.pngfacebook.png
  • twitter.pngtwitter.png
  • linkedin.pnglinkedin.png
Texas Liver Institute
  • Home
  • About
    • Research
    • Austin Clinic
    • Dallas Clinic
    • Vision & Mission
    • Physicians & Providers
    • Affiliations
    • Events
    • Disclosures
  • Services
    • Clinical Services
    • Nutrition Information
  • Education
    • About Your Liver
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C (HCV)
    • Chronic Hepatitis C
    • Autoimmune Hepatitis
    • Cirrhosis
    • Fatty Liver Disease
    • Liver Cancer
    • Hemochromatosis
    • Hepatocellular Carcinoma (HCC)
    • Primary Biliary Cholangitis (PBC)
    • Primary Sclerosing Cholangitis (PSC)
    • Health and Wellness
  • Research Studies
  • Patient Resources
    • Patient Portal
    • Telemedicine Consent
    • What to Bring to Your Appointment
    • What to Expect During Your Visit
    • Working with Your Insurance
    • Our Financial Policies
    • Understanding Your Bill
    • Privacy Policy and HIPAA
    • FAQs
    • Patient Forms
  • Liver Updates
    • Liver News
    • Newsletters
    • Video Lectures
    • Slide Presentations
    • Most Recent Publications
  • Contact
    • Contact Us
    • Request Appointment!
    • Physican Referrals
    • Careers

Nov 30 2020

TLI Quarterly — Fall 2020

Sean Hendrickson

Newsletters

This edition contains the following: TLI Welcomes Dr. Rita Lepe, Director of Hepatology Health Disparities Studies Hispanics and Liver Disease So Close But Yet So Far…Promising Drugs That Came Up

Read More

Mar 24 2020

TLI Quarterly — Spring 2020

Sean Hendrickson

Newsletters

This edition contains the following: First FDA-Approved NASH Drug Expected in 2020: Quick Facts to Know The Tussle Between Resection and Liver Transplantation in the Treatment of HCC “What advice

Read More

May 13 2019

TLI Quarterly — Spring 2019

Sean Hendrickson

Newsletters

This edition contains the following: Living Donor Liver Transplantation An Update on Nonalcoholic Steatohepatitis (NASH) from the International Liver Congress Does direct-acting antiviral exposure affect hepatocellular carcinoma recurrence in patients

Read More

Nov 06 2018

TLI Quarterly — Fall 2018

Sean Hendrickson

Newsletters

This edition contains the following: A New First-Line Oral Treatment for Advanced Hepatocellular Carcinoma Comprehensive, Cutting-Edge Care at The Texas Liver Tumor Center An Update on the Management of Severe

Read More

Apr 08 2018

TLI Quarterly — Spring 2018

Sean Hendrickson

Newsletters

This edition contains the following: Autoimmune Hepatitis: Current And Future Treatment Options Cholangiocarcinoma: Diagnosis And Management Is Green Tea Good For Your Health? What Noninvasive Imaging Techniques Can Measure Liver

Read More

Nov 19 2017

TLI Quarterly — Fall 2017

Sean Hendrickson

Newsletters

This edition contains the following: New Targeted Therapy for HCC Can my patients take over-the-counter herbal and dietary supplements? NAFLD/NASH Update

Read More

Aug 05 2017

TLI Quarterly — Summer 2017

Sean Hendrickson

Newsletters

This edition contains the following: TLI Welcomes Dr. Fabian Rodas Opening of Texas Liver Tumor Center (TLTC) HCC in South Texas Latinos: Is Aflatoxin Exposure Partly to Blame? A Focus on Benign

Read More

Apr 15 2017

TLI Quarterly — Spring 2017

Sean Hendrickson

Newsletters

This edition contains the following: Dr. Naim Alkhouri, Joins Texas Liver Institute and UT Health Oral Nutrition Supplement for a Patient with Cirrhosis How to Make Low Sodium Diet Appealing to Patients Hepatitis

Read More

Oct 11 2016

TLI Quarterly — Fall 2016

Sean Hendrickson

Newsletters

This edition contains the following: How Much Alcohol Can I Safely Drink? Does Liver Disease Hurt? Does Replacing Animal Protein With Plant Protein Help People Live Longer? Primary Biliary Cholangitis

Read More

Apr 11 2016

TLI Quarterly — Spring 2016

Sean Hendrickson

Newsletters

This edition contains the following: Frequently Asked Questions on Liver Disease Managing HCV-infected Patients With Decompensated Cirrhosis Nutritional Guidelines for Fat Malabsorption in Cholestatic Liver Disease

Read More
  • 1
  • 2
Next

Patient Education

  • About Your Liver
  • Hepatitis
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C (HCV)
    • Chronic Hepatitis C
    • Autoimmune Hepatitis
  • Fatty Liver Disease
  • Liver Cancer
  • Cirrhosis
  • Hemochromatosis
  • PBC/PSC

Appointments

  • Schedule an Appointment!
  • What to Bring to Your Appointment
  • What to Expect During Your Visit
  • Working with Your Insurance
  • Our Financial Policies
  • Privacy Policy and HIPAA
  • FAQs
  • Patient Forms

Contacts

San Antonio

607 Camden St
Suite 101
San Antonio, Texas 78215

Phone : 210-253-3426

Fax : 210-227-6951

Austin

7940 Shoal Creek Blvd
Suite 205
Austin, Texas 78757

Phone : 512-454-8378

Fax : 512-454-8375

Dallas

7515 Greenville Ave
Suite 600
Dallas, Texas 75231

Phone : 214-945-2521

Fax : 214-945-2524


Disclosures
Copyright © 2020 Texas Liver Institute All Rights Reserved
Texas Liver Institute